Ron Martell's Net Worth

$7.43 Million

Estimate Recalculated Nov 1, 2024 04:31AM EST

Who is Ron Martell?

Ron Martell has an estimated net worth of $7.43 Million. This is based on reported shares across multiple companies, which include NeurogesX Inc, Jasper Therapeutics, Inc., PONIARD PHARMACEUTICALS, INC., KALOBIOS PHARMACEUTICALS INC, CYTORI THERAPEUTICS, INC., Sevion Therapeutics, Inc., and IMCLONE SYSTEMS INC/DE.

SEC CIK

Ron Martell's CIK is 0001177079

Past Insider Trading and Trends

2006 was Ron Martell's most active year for acquiring shares with 8 total transactions. Ron Martell's most active month to acquire stocks was the month of December. 2006 was Ron Martell's most active year for disposing of shares, totalling 7 transactions. Ron Martell's most active month to dispose stocks was the month of July. 2008 saw Ron Martell paying a total of $447,000.00 for 150,000 shares, this is the most they've acquired in one year. In 2006 Ron Martell cashed out on 56,777 shares for a total of $1,110,551.39, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NeurogesX Inc No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
25K
—
—
25K
Jan 1
Form 4
—
0
—
—
0
Mar 13
Form 4/A
—
0
—
—
0
Jan 30
Form 4
—
0
—
—
0
Jan 30
Form 3
—
0
—
—
0
No matching records found

Jasper Therapeutics, Inc. (JSPR) Snapshot price: $18.63

President, CEO and Director

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Feb 15
Form 4
-20.90%
-87.53K
$0.85
-$74,401.35
331.19K
Oct 12
Form 4
-17.29%
-87.53K
$1.46
-$127,795.26
418.72K
Apr 12
Form 4
—
0
—
—
0
Mar 17
Form 4
—
0
—
—
0
Feb 2
Form 4
∞
506.25K
—
—
506.25K
Oct 12
Form 4
—
0
—
—
0
Mar 21
Form 3
—
0
—
—
0
No matching records found

PONIARD PHARMACEUTICALS, INC. No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.78%
25K
—
—
548.07K
Oct 6
Form 4
+45.07%
162.5K
—
—
523.07K
Apr 9
Form 4
—
0
—
—
0
Feb 15
Form 4
+9.49%
31.25K
—
—
360.57K
Feb 7
Form 4
+8.21%
25K
—
—
329.32K
Oct 6
Form 4
+2,411.95%
292.21K
—
—
304.32K
Dec 31
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Apr 9
Form 4
∞
12.12K
$1.24
$15,046.60
12.12K
Mar 25
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
Oct 6
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 26
Form 3
—
0
—
—
0
No matching records found

KALOBIOS PHARMACEUTICALS INC (HGEN) Snapshot price: $0.011

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 28
Form 4
—
0
—
—
0
Sep 28
Form 4
—
0
—
—
0
Aug 28
Form 4
—
0
—
—
0
Jul 30
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Apr 22
Form 3
—
0
—
—
0
No matching records found

CYTORI THERAPEUTICS, INC. (PSTV) Snapshot price: $1.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 26
Form 3
—
0
—
—
0
No matching records found